INTELLIGENT BIO SOLUTIONS INC. Leases Disclosure
NOTE 13. LEASES
The Company has two non-cancellable operating leases with original lease periods expiring in August 2025 and April 2026.
The components of operating lease expense are as follows:
| Year Ended June 30, | ||||||||
| 2025 | 2024 | |||||||
| Amortization of operating lease right-of-use assets | $ | 243,632 | $ | 238,730 | ||||
| Interest on operating lease liabilities | 4,269 | 71,667 | ||||||
| Total lease expense | $ | 247,901 | $ | 310,397 | ||||
As of June 30, 2025 and 2024, the weighted average remaining lease-term was 0.5 years and 1.3 years, respectively, and the weighted-average discount rate was 13.2%.
The reconciliation of the maturities of the operating leases to the operating lease liabilities recorded in the consolidated balance sheet as of June 30, 2025, is as follows:
| 2026 | $ | 86,910 | ||
| Total lease payments | 86,910 | |||
| Less: present value discount | (2,251 | ) | ||
| Lease liabilities | $ | 84,659 |
About Leases Disclosures
Lease disclosures under ASC 842 provide a comprehensive view of a company's leased asset portfolio, including the split between operating and finance leases, discount rates used to present-value future payments, and the maturity schedule of lease obligations. This section reveals a significant source of off-balance-sheet commitments that were largely hidden before the current standard.
Key signals: the weighted-average discount rate affects the size of recorded lease liabilities — a higher rate reduces the reported obligation, so compare the chosen rate against the company's incremental borrowing rate. The operating versus finance lease mix affects both EBITDA and operating income presentation. Watch the maturity table for concentration risk: large payment cliffs in specific years may create cash flow pressure. Variable lease payments excluded from the liability measurement represent real obligations that do not appear on the balance sheet. Compare total lease costs against prior-year operating lease expense to assess the true economic burden.